Hims & Hers Health is trading 6.3% down at €28.78 following a sharp pullback from a recent sector-driven rebound in healthcare names.
- The move follows earlier gains tied to strength in medical device and clinical research peers rather than any new company-specific catalyst.
- The stock appears to be reacting primarily to shifting sector dynamics and broader market sentiment rather than fundamental changes.